Form 4: Kewaunee Scientific CEO Sells 2,000 Shares

Sentiment:

SEC Form 4 Filing


Kewaunee Scientific Corp's CEO, Thomas David Hull III, sold 2,000 shares of common stock on December 26, 2024.

Summary

  • Thomas David Hull III, the President and CEO of Kewaunee Scientific Corp, sold 2,000 shares of common stock on December 26, 2024.
  • The sale was executed at a weighted average price of $63.01 per share.
  • The prices ranged from $62.78 to $63.59 per share.
  • Following the transaction, Mr. Hull directly owns 42,497 shares of Kewaunee Scientific Corp.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, with no inherent positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the transactions of key personnel.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for publicly traded companies in the United States.
  • The transaction is typical for executives who may sell shares for personal financial management or diversification purposes.
  • The sale is not unusual in the context of executive compensation and stock ownership.

Stakeholder Impact

  • The sale may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial health.

Key Dates

DateDescription
12/26/2024Date of the stock sale transaction.
12/27/2024Date the form was signed by the attorney-in-fact.

Keywords

Kewaunee Scientific Corp, stock sale, insider trading, Thomas David Hull III, CEO, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.